$CYTR Company News CytRx's stock spike proves to be no

New Post Public Reply Private Reply Replies (0) Message Board

Dec 12, 2013 at 2:34 PM

$CYTR Company News

CytRx's stock spike proves to be no fluke with another 20% share gain 11:39 a.m. Today - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 4:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 10:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 9:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 5:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 7:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 10:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 11:49 a.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 10:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 1:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 8:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 1:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx halts trial of ALS treatment 7:50 a.m. Jan. 22, 2008 - Angela Moore
FDA puts hold on CytRx's Phase IIb arimoclomol trial 7:34 a.m. Jan. 22, 2008 - Michael Kitchen

CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase 2B Tests 12:28 p.m. Today - Seeking Alpha
CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase IIB Tests 12:28 p.m. Today - Seeking Alpha
Perilous Reversal Watch: CytRx Corporation (CYTR) 9:55 a.m. Today - TheStreet.com
CytRx Corporation Soars on Positive Phase 2b Sarcoma Data 1:38 p.m. Dec. 11, 2013 - Wall St. Cheat Sheet
Why CytRx (CYTR) Is Exploding on Wednesday 1:32 p.m. Dec. 11, 2013 - TheStreet.com
CytRx's Sarcoma Treatment Shows Positive Results 9:48 a.m. Dec. 11, 2013 - WSJ.com
Morning Market Movers 8:56 a.m. Dec. 11, 2013 - benzinga.com
CytRx reports positive top-line data from aldoxorubicin STS trial 8:23 a.m. Dec. 11, 2013 - Seeking Alpha
CytRx Corporation Offers Hope for Brain Cancer Patients 11:23 a.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Top Insider Trades: CYTR TROX KTOS MDGN 9:50 a.m. Dec. 4, 2013 - TheStreet.com
CytRx rallies after conference presentation 8:19 a.m. Dec. 4, 2013 - Seeking Alpha
Aegis still positive on CytRx, sees big upside 9:50 a.m. Nov. 25, 2013 - Seeking Alpha
CytRx Initiates Phase 2 Aldoxorub Trial in Patients with Unresectable GBM Brain Cancer 7:40 a.m. Nov. 20, 2013 - benzinga.com
A Small Cap That is Cashing In on ObamaCare 3:44 p.m. Nov. 19, 2013 - benzinga.com
Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment 10:40 a.m. Nov. 19, 2013 - Seeking Alpha
CytRx Surges Ahead With Positive Drug Data 7:41 a.m. Nov. 1, 2013 - Seeking Alpha
CytRx Announces Further Positive Clinical Data from Global Phase 2b Aldoxorubicin Study 5:03 a.m. Oct. 31, 2013 - benzinga.com
10-Q: CYTRX CORP 6:02 a.m. Oct. 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
CytRx Says Wins FDA Acceptance for Protocol of Phase 2 Aldoxorubicin in Glioblastoma Trial 7:36 a.m. Oct. 23, 2013 - benzinga.com
CytRx Awaiting Soft Tissue Sarcoma Data In December 8:56 a.m. Oct. 17, 2013 - Seeking Alpha

Bullish Stocks Radar: CytRx Corporation, Echo Therapeutics Inc, Advanced Micro Devices, Inc, Baidu Inc 9:02 a.m. Dec. 11, 2013 - ACCESSWIRE
CytRx Reports Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial 8:17 a.m. Dec. 11, 2013 - BusinessWire
CytRx to Hold Conference Call December 11, 2013 at 10:30 a.m. Eastern Time to Discuss Results of Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas 5:30 p.m. Dec. 10, 2013 - BusinessWire
CytRx Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11th, 2013 8:30 a.m. Dec. 4, 2013 - BusinessWire
CytRx to Present at the Sixth Annual LD MICRO "Main Event" Conference in Los Angeles on December 3, 2013 8:30 a.m. Nov. 26, 2013 - BusinessWire
CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme (Brain Cancer) 8:30 a.m. Nov. 20, 2013 - BusinessWire
MissionIR Releases Exclusive Audio Interview With CytRx Management 8:31 a.m. Nov. 7, 2013 - Marketwire
CytRx Reports Further Positive Interim Data from Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas 5:00 a.m. Oct. 31, 2013 - BusinessWire
CytRx Reports 2013 Third Quarter Financial Results 5:00 a.m. Oct. 29, 2013 - BusinessWire
Hot Topic: Breast Cancer Awareness Month 2013 7:08 a.m. Oct. 25, 2013 - BusinessWire
CytRx Announces Closing of Public Offering of Common Stock 11:45 a.m. Oct. 15, 2013 - BusinessWire
CytRx Announces Exercise of Underwriters' Over-Allotment Option 6:00 p.m. Oct. 11, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
CytRx Announces Pricing of Public Offering of 10.0 Million Shares of Common Stock 8:15 p.m. Oct. 8, 2013 - BusinessWire
CytRx Announces Proposed Public Offering of Common Stock 3:20 p.m. Oct. 8, 2013 - BusinessWire
OtcbbJournal.com, Where Savvy Traders Get Their Small-Cap Stock Research 7:02 a.m. Sept. 30, 2013 - Marketwire
CytRx's New Aldoxorubicin Data Demonstrates Significant Advantages over Doxorubicin 5:00 a.m. Sept. 30, 2013 - BusinessWire
CytRx to Present at the Aegis Capital Corp. 2013 Healthcare Conference 7:30 a.m. Sept. 23, 2013 - BusinessWire
CytRx to Present at the Rodman & Renshaw Global Investment Conference 7:30 a.m. Sept. 3, 2013 - BusinessWire
CytRx Reports 2013 Second Quarter Financial Results 7:30 a.m. Aug. 6, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

StackRails Unleashes AI Power with Contextual Clarity

AI's Blind Spots Exposed Let's get this straight—plugging AI into enterprise coding projects without context is like sending a blindfolded sprinter onto a city's marathon route. Sure, they'll move, but who knows what havoc they'll wreak along the way? That's where StackRails steps up to the plate, aiming to dispel the chaos with a robust grip on the bigger picture. The...

Instanodes Tackling Quantum Threats in Blockchain

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Emotional Products Steal the Show at Canton Fair

Canton Fair's Emotional Revolution Amidst the bustling aisles of the 140th Canton Fair in Guangzhou, something interesting has gotten folks buzzing. The market's tilting its head towards products that spark joy and dance with emotion, rather than just bland utility. That's right, the time-honored relationship between value and function is giving way to a softer kind of...

Tom Doyle Takes Helm at Gallagher's HR Consulting

Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...

Envision's Green Ammonia Powers Game-Changing Shipping Milestone

Envision's Big Bet on Green Ammonia It's a day to talk about paradigms shifting on the high seas. Envision, a heavy hitter in the green tech arena, just fueled the very first Very Large Ammonia Carrier (VLAC) with their certified green ammonia. Now, that's not just a milestone, it’s like finding a four-leaf clover in the world of maritime decarbonization—a tough nut...

Duke Energy Florida Plans Major Rate Cut for 2027

Slashing Rates to Keep Customers Happy Staring down utility bills isn't anyone's favorite pastime, but there's some good news for folks under Duke Energy Florida's wings. Come January 2027, customers throughout the Sunshine State are in for a surprise on their electricity bills—lower numbers! A $33 slash in the typical residential power bill could be just around the...

Coretek Joins CRN's Elite AI Innovators of 2026

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Qfin Holdings Faces Securities Fraud Class Action Challenges

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Eastern Championship: Collegiate Cricket's U.S. Surge

Cricket's American Dream Marches On Out of the woodwork comes the Collegiate Cricket League's 2026 Eastern Championship set to unfold near Washington, D.C., from Nov. 6-8. Now, nobody's saying cricket is overtaking the popularity of football or basketball stateside, but this three-day slugfest at Hal & Berni Hanson Regional Park in Aldie, Virginia, isn't just for...

SlidesAI Launches Standalone Platform for Presentations

From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...